The use of single-pill combinations as first-line treatment for hypertension: translating guidelines into clinical practice-Reference-Cited by-同舟云学术

The use of single-pill combinations as first-line treatment for hypertension: translating guidelines into clinical practice

Published:2020-08-21 Issue:12 Volume:38 Page:2369-2377
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Campana Erika,Cunha Vitória,Glaveckaite Sigita,Gruev Ivan,Lamirault Guillaume,Lehmann Elke,Masi Stefano,Mfeukeu Kuate Liliane,Mishshenko Larysa,Ona Deborah I.D.,Oo Min Zaw,Tautu Oana G.F.,Vachulova Anna,Vintila Ana-Maria,Wolf Jacek,Zvartau Nadezhda,Narkiewicz Krzysztof,Laurent Stephane

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference66 articles.

1. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries;Mills;Circulation,2016

2. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries;Chow;JAMA,2013

3. May measurement month 2017: an analysis of blood pressure screening results worldwide;Beaney;Lancet Glob Health,2018

4. Antihypertensive drug therapy and blood pressure control in men and women: an international perspective;Thoenes;J Hum Hypertens,2010

5. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT);Cushman;J Clin Hypertens (Greenwich),2002

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Validation of Stability Indicating HPTLC Methods for the Estimation of Antihypertensive Drugs (Nebivolol and Hydrochlorothiazide);Journal for Research in Applied Sciences and Biotechnology;2024-07-06

2. Therapy and guideline adherence at a multidisciplinary hypertension clinic: A prospective, observational study;Vascular Pharmacology;2024-03

3. Roadmap for the Management of Type 2 Diabetes and Hypertension in the Middle East: Review of the 2022 EVIDENT Summit;Advances in Therapy;2023-05-26

4. Advances in pathogenesis and treatment of essential hypertension;Frontiers in Cardiovascular Medicine;2022-10-14

5. TIMES TO ACT. Italian-Spanish-Polish-Uzbek Expert Forum Position Paper 2022. Dyslipidemia and arterial hypertension: The two most important and modifiable risk factors in clinical practice;Cardiology Journal;2022-09-30